Education
About Us
Working with TipRanks
Follow Us
Alcon Inc (ALC)
NYSE:ALC
ALC Analyst Ratings
Strong Buy
15 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ALC Stock 12 Month Forecast
Average Price Target
$105.45
▲(13.63% Upside)
| Highest Price Target$115.00 | Average Price Target$105.45 | Lowest Price Target$90.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
Upgraded
03/25/25
Bernstein
Reiterated
03/25/25
Stifel Nicolaus
Reiterated
03/25/25
Berenberg Bank
Reiterated
03/20/25
Needham
Reiterated
03/20/25
RBC Capital
Reiterated
03/05/25
Deutsche Bank
Reiterated
03/04/25
Wells Fargo
Reiterated
02/28/25
Morgan Stanley
$85→$90
Hold
-3.02%
Downside
Reiterated
02/28/25
Morgan Stanley Keeps Their Hold Rating on Alcon (ALC)
Robert W. Baird
$104→$108
Buy
16.38%
Upside
Reiterated
02/27/25
Alcon price target raised to $108 from $104 at BairdAlcon price target raised to $108 from $104 at Baird
Mizuho Securities
$110→$115
Buy
23.92%
Upside
Reiterated
02/27/25
Analysts Conflicted on These Healthcare Names: Agilon Health (NYSE: AGL), AN2 Therapeutics, Inc. (NASDAQ: ANTX) and Alcon (NYSE: ALC)We note that this comes in spite of the investment necessary to stand up/research its extensive pipeline coming to market near- term: 1) updated Vitroretinal Cataract System (VCS) UNITY launching 2Q25, 2) PRECISION7 weekly contact lens broader commercial launch, 3) PanOptix Pro next-gen IOL with potential 1H25 launch, 4) Dry eye potential submission, 5) BELKIN selective laser trabeculoplasty (SLT) new product flow, and 6) a next-gen eye drop, among others. We expect these devices and impact to be covered extensively at ALC's late-March '25 investor day, but we see 2025 guidance as a strong jump-off point for ALC's next margin expansion leg.
J.P. Morgan
$89.5→$105.88
Buy
14.09%
Upside
Reiterated
02/27/25
Alcon Inc. (ALC) PT Raised to $105.88 at JPMorganJPMorgan analyst David Adlington raised the price target on Alcon Inc. (NYSE: ALC) to $105.88 (from $89.50) while maintaining a Overweight rating.
BTIG
$99→$102
Buy
9.91%
Upside
Reiterated
02/26/25
Alcon's Strong Q4 Performance and Strategic Growth Initiatives Earn Buy Rating from AnalystWe will update our model following the full 4Q24 earnings call.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Upgraded
03/25/25
Bernstein
Reiterated
03/25/25
Stifel Nicolaus
Reiterated
03/25/25
Berenberg Bank
Reiterated
03/20/25
Needham
Reiterated
03/20/25
RBC Capital
Reiterated
03/05/25
Deutsche Bank
Reiterated
03/04/25
Wells Fargo
Reiterated
02/28/25
Morgan Stanley
$85→$90
Hold
-3.02%
Downside
Reiterated
02/28/25
Morgan Stanley Keeps Their Hold Rating on Alcon (ALC)
Robert W. Baird
$104→$108
Buy
16.38%
Upside
Reiterated
02/27/25
Alcon price target raised to $108 from $104 at BairdAlcon price target raised to $108 from $104 at Baird
Mizuho Securities
$110→$115
Buy
23.92%
Upside
Reiterated
02/27/25
Analysts Conflicted on These Healthcare Names: Agilon Health (NYSE: AGL), AN2 Therapeutics, Inc. (NASDAQ: ANTX) and Alcon (NYSE: ALC)We note that this comes in spite of the investment necessary to stand up/research its extensive pipeline coming to market near- term: 1) updated Vitroretinal Cataract System (VCS) UNITY launching 2Q25, 2) PRECISION7 weekly contact lens broader commercial launch, 3) PanOptix Pro next-gen IOL with potential 1H25 launch, 4) Dry eye potential submission, 5) BELKIN selective laser trabeculoplasty (SLT) new product flow, and 6) a next-gen eye drop, among others. We expect these devices and impact to be covered extensively at ALC's late-March '25 investor day, but we see 2025 guidance as a strong jump-off point for ALC's next margin expansion leg.
J.P. Morgan
$89.5→$105.88
Buy
14.09%
Upside
Reiterated
02/27/25
Alcon Inc. (ALC) PT Raised to $105.88 at JPMorganJPMorgan analyst David Adlington raised the price target on Alcon Inc. (NYSE: ALC) to $105.88 (from $89.50) while maintaining a Overweight rating.
BTIG
$99→$102
Buy
9.91%
Upside
Reiterated
02/26/25
Alcon's Strong Q4 Performance and Strategic Growth Initiatives Earn Buy Rating from AnalystWe will update our model following the full 4Q24 earnings call.
ALC Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
24
21
21
17
23
Hold
4
5
3
5
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
26
24
22
28
Each month's total comprises the sum of three months' worth of ratings.
ALC Financial Forecast
ALC Stock Forecast FAQ
What is ALC’s average 12-month price target, according to analysts?
Based on analyst ratings, Alcon Inc’s 12-month average price target is $105.45.
What is ALC’s upside potential, based on the analysts’ average price target?
Alcon Inc has 13.63% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ALC a Buy, Sell or Hold?
Alcon Inc has a consensus rating of Strong Buy which is based on 15 buy ratings, 3 hold ratings and 0 sell ratings.
What is Alcon Inc’s price target?
The average price target for Alcon Inc is $105.45. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $115.00 ,the lowest forecast is $90.00. The average price target represents 13.63% Increase from the current price of $92.8.
The highest analyst price target is $115.00 ,the lowest forecast is $90.00. The average price target represents 13.63% Increase from the current price of $92.8.
What do analysts say about Alcon Inc?
Alcon Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of ALC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.